Medochemie, Cyprus’ leading pharmaceutical company, is strengthening its commitment to sustainable growth by taking another significant step towards a greener future. As of October 1, 2025, all of its manufacturing facilities are now powered exclusively by green energy generated from photovoltaic parks.
This new energy policy covers the company’s total annual electricity consumption, approximately 18,000,000 kWh. The transition drastically reduces reliance on conventional power generation and leads to a reduction of 12,186,000 kilograms of CO₂ emissions each year, making a tangible contribution to combating climate change and protecting the environment.
The initiative forms part of Medochemie’s long-term strategy for environmental responsibility and innovation, which…
